Showing posts with label HSCT Market. Show all posts
Showing posts with label HSCT Market. Show all posts

Friday, 6 October 2017

At A CAGR Of 5.75% Global Hematopoietic Stem Cells Transplantation (HSCT) Market Will Grow During The Period 2017-2021 Key vendors – AllCells, Lonza, Merck, Sanofi

Researchmoz added Most up-to-date research on "Global Hematopoietic Stem Cells Transplantation (HSCT) Market 2017-2021" to its huge collection of research reports.

HSCT is the most widely used stem-cell therapy, where blood from umbilical cord is used. Research is being undertaken to discover various sources (such as cord blood cells, bone marrow, and peripheral blood cells) of hematopoietic stem cells to treat various disorders like hematological malignancies, blood related disorders (leukemia and lymphoma), neurodegenerative diseases and conditions such as heart disease, diabetes, and other conditions.

Stem-cell therapy has become controversial after developments in isolating and culturing of embryonic stem cells. Somatic cell nuclear transfer is the technique used in embryonic stem cell research to create stem cells and induced pluripotent stem cells. This controversy is related to abortion policies and human cloning. However, the changing regulatory landscape in countries like the US and Japan may help to accelerate the clinical trials.

Technavios analysts forecast the global hematopoietic stem cells transplantation (HSCT) market to grow at a CAGR of 5.75% during the period 2017-2021.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1336387

Covered in this report
The report covers the present scenario and the growth prospects of the global hematopoietic stem cells transplantation (HSCT) market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of hematopoietic stem cells transplantation (HSCT).

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Global Hematopoietic Stem Cells Transplantation (HSCT) Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
AllCells
Lonza
Merck
Sanofi

Browse Detail Report With Full TOC @ https://www.researchmoz.us/global-hematopoietic-stem-cells-transplantation-hsct-market-2017-2021-report.html

Other prominent vendors
Athersys
Beike Biotechnology
BioTime
bluebird bio
Caladrius
Cellular Biomedicine Group
Cellular Dynamics International (a subsidiary of Fujifilm)
Cesca Therapeutics
CHA Biotech
CORESTEM
Gamida Cell
Global Stem Cells Group
Hemostemix
Histocell
Mesoblast
TiGenix
Translational Biosciences (a subsidiary of Medistem Panama)

Market driver
Rising number of HSCT
For a full, detailed list, view our report

Market challenge
High cost of HSCT
For a full, detailed list, view our report

Market trend
Growing demand for personalized medicine
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?

Make an Enquiry of this report @ https://www.researchmoz.us/enquiry.php?type=E&repid=1336387

Sunday, 24 September 2017

Worldwide HSCT Market Is Estimated To Increase At A CAGR Of 12.80% From 2017 To 2025, Rising To US$37.61 bn

Researchmoz added Most up-to-date research on "Hematopoietic Stem Cell Transplantation (HSCT) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024" to its huge collection of research reports.

Global Hematopoietic Stem Cell Transplantation (HSCT) Market: Overview


This report on Hematopoietic Stem Cell Transplantation (HSCT) market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of HSCT as well as new entrants planning to enter this market.

To Get Sample Copy of Report visit @ https://www.researchmoz.us/enquiry.php?type=S&repid=1109478

This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered within the scope of the study. This section also provides the overall information and data analysis of the global HSCT market with respect to the leading market segments based on transplants types, disease indication, applications and geographies.

The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the global hematopoietic stem cell transplantation (HSCT) market and could influence the market in the near future. Market attractiveness analysis has been provided in all the sections of the report in order to explain the intensity of competition in the market across different transplants/disease indication/applications/geographies. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the global market.

Global Hematopoietic Stem Cell Transplantation (HSCT) Market: Segmentation

The global hematopoietic stem cell transplantation (HSCT) market is divided into: by transplant type, by disease indication, by application and by geography. Transplant type segment of HSCT market was divided into autologous transplant and allogeneic transplant. While allogeneic transplant was further segmented into family related and unrelated transplant. On the basis of disease indication the market was divided into lymphoproliferative disorders, leukemia, non-malignant disorders. On the basis of application the hematopoietic stem cell transplantation (HSCT) market is divided as peripheral blood stem cells transplant (PBSCT), bone marrow transplant (BMT), and cord blood transplant (CBT).

Geographically, the hematopoietic stem cell transplantation (HSCT) market has been segmented into five regions: North America, Europe, Asia Pacific, Europe, Middle East & Africa (MEA), and Latin America. Each regional market for HSCT market has been further categorized into major transplant type, disease indication, and application segments considered within the scope of the study. Key country (U.S., Canada, Japan, Germany, France, U.K., Australia, Canada, China, Brazil, Mexico, India, etc.) market revenues have also been provided in different regional sections within the report.

The market for these segments has been extensively analyzed based on their utility, effectiveness, sales, and geographic presence. Market revenue in terms of US$ Mn and market volume in terms of units for the period from 2017 to 2025, along with the compound annual growth rate (CAGR %) from 2017 to 2025) are provided for all segments, considering 2016 as the base year. Market revenue in terms of US$ Mn and volume in terms of units for the period from 2015 to 2025 along with CAGR % from 2016 to 2025 are provided for all the regions and nations considering 2016 as the base year.

Browse Detail Report With Full TOC @ https://www.researchmoz.us/hematopoietic-stem-cell-transplantation-hsct-market-global-industry-analysis-size-share-growth-trends-and-forecast-2016-2024-report.html

Companies Mentioned in the Report

The report profiles key manufacturers in the hematopoietic stem cell transplantation (HSCT) Market based on various attributes such as company details, SWOT analysis, strategic overview, financials, and business overview. Major players profiled in this report include Regen Biopharma, Inc., Escape Therapeutics, Inc., Lonza Group Ltd., and Pluristem Therapeutics Inc.

The global hematopoietic stem cell transplantation (HSCT) Market has been segmented as follows:

By Transplant Type

- Allogeneic
- Family Related
- Unrelated
- Autologous

By Disease Indication

- Lymphoproliferative disorders
- Leukemia
- Non-malignant Disorders-

By Application

- Peripheral Blood Stem Cells Transplant (PBSCT)
- Bone Marrow Transplant (BMT)
- Cord Blood Transplant (CBT)

By Region

- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa

Make an Enquiry of this report @ https://www.researchmoz.us/enquiry.php?type=E&repid=1109478

Blood Thawing System Market Insights Shared in Detailed Report

Blood Thawing System Market: Introduction According to the report, the global  blood thawing system market  was valued at ~US$ 174 Mn in 2...